Novel biomarkers in heart failure with preserved ejection fraction
- PMID: 24975910
- DOI: 10.1016/j.hfc.2014.04.005
Novel biomarkers in heart failure with preserved ejection fraction
Abstract
Heart failure with preserved ejection fraction (HFPEF) is a common subtype of heart failure with morbidity and mortality similar to that of heart failure with systolic dysfunction. This article discusses the numerous biomarkers that promise to play a substantial role in terms of our ability to understand the mechanisms of HFPEF and discern possible phenotypes that respond to targeted therapies: natriuretic peptides, high-sensitivity troponins, galectin-3, soluble ST2, neutrophil gelatinase-associated lipocalin, and cystatin C.
Keywords: Biomarkers; Diagnosis; Heart failure; Preserved ejection fraction; Prognosis.
Published by Elsevier Inc.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
